Amy Wendell

Amy Wendell is an accomplished board member with extensive experience in the healthcare and medical technology sectors. Currently serving on the boards of Baxter International Inc., Hologic, Inc., Axogen, and Por Cristo, Wendell has contributed to organizations impactful in patient care and medical innovation. Previously, Wendell held senior advisory roles at McKinsey and Company and Perella Weinberg Partners, focusing on strategy and corporate finance within healthcare. Wendell's notable tenure as Senior Vice President of Strategy and Business Development at Covidien included leadership in M&A, strategic planning, and business development initiatives. Wendell holds a Master’s Degree in Biomedical Engineering from the University of Illinois Chicago and a Bachelor’s Degree in Mechanical Engineering from Lawrence Technological University.